Business Segment Information (Tables)

6 Months Ended

Jun. 30, 2022

Segment Reporting [Abstract]

Schedule of Revenue, Operating Income and Total Assets by Reportable Segment

Revenue and operating income by reportable segment are presented below (in millions):

	Three Months Ended June 30,						Six Months Ended June 30,
	2022			2021			2022			2021
Revenue:
BSI Life Science	$	350.1		$	341.8		$	711.1		$	693.6
BSI Nano		182.2			175.3			360.7			329.7
BEST		59.2			56.6			118.9			109.0
Eliminations (a)		(3.1	)		(2.9	)		(7.3	)		(6.8	)
Total revenue	$	588.4		$	570.8		$	1,183.4		$	1,125.5
Operating income (loss):
BSI Life Science	$	70.2		$	73.6		$	156.1		$	162.5
BSI Nano		14.6			21.0			36.9			33.3
BEST		6.6			6.8			13.2			10.9
Corporate, eliminations and other (b)		(17.5	)		(15.8	)		(35.8	)		(32.0	)
Total operating income	$	73.9		$	85.6		$	170.4		$	174.7

(a)Represents product and service revenue between reportable segments.

(b)Represents corporate costs and eliminations not allocated to the reportable segments.

Total assets by reportable segment are as follows (in millions):

	June 30, 2022			December 31, 2021
Assets:
BSI Life Science, BSI Nano & Corporate	$	3,298.3		$	3,560.5
BEST		93.1			97.9
Eliminations and other (a)		(6.6	)		(8.4	)
Total assets	$	3,384.8		$	3,650.0

(a)Assets not allocated to the reportable segments and eliminations of intercompany transactions.